Researchers found that strong interactions between immune receptors promote antidrug antibody production, increasing the risk ...

Antibodies have transformed the way physicians treat patients with different pathologies. The next generation of monoclonal ...

A herb commonly sold in cold and flu supplements may no longer be classified as “low-risk”, after Australia’s therapeutic goods regulator found it can cause severe allergic reactions and even death.

The FDA added a boxed warning about rare cases of anaphylaxis associated with the multiple sclerosis (MS) drug glatiramer acetate (Copaxone, Glatopa), the agency announced on Wednesday. The warning ...

New research based on real-world data largely aligns with the scientific literature, although one monoclonal antibody—dupilumab—stood out for its very low risk. Patients receiving monoclonal ...

A new study by clinical researchers at Baylor College of Medicine and Texas Children’s Hospital offers insight on the primary triggers and management of childhood anaphylaxis. This severe, ...

SAN ANTONIO -- Many reported anaphylactic reactions to COVID-19 vaccination may in fact be attributable to vaccine-induced immunization stress-related response (ISRR), suggested findings from a small ...

Anaphylaxis is the most extreme form of severe allergic reactions which can be life threatening and requires emergency medical treatment. It can affect anyone of any age, sex, race and stature.

Anaphylaxis can cause severe itching, difficulty breathing, fainting, and abdominal pain. These symptoms usually begin about 30 minutes after coming into contact with an allergy trigger. First, call ...

Many kinds of allergic reactions are more annoying than harmful. Not anaphylaxis (pronounced an-uh-fil-LAX-is). If not addressed promptly, it can cause a potentially fatal condition called ...